TransEnterix (NYSE:TRXC) said today that its president and CEO Todd Pope has been named to Time Magazine’s Most Influential People in Health Care for 2018, highlighted for their work bringing the Senhance robotic surgical platform to the market.
Pope was an inaugural selection for the list, which Time Magazine said it assembled to highlight “physicians, scientists, and business and political leaders whose work is transforming health care right now.”
Time lauded Pope and TransEnterix for offering “budget-friendly features” for the Senhance system which they said “helps hospitals make up for the sizable up-front investment of buying a surgical robot.” Pope told the magazine that he envisions a world where every hospital would have access to the Senhance system, regardless of their budgetary restrictions.
“It’s not just good enough to introduce some interesting technology that can benefit patients, it also has to fit within a constrained budget environment,” Pope told Time Magazine.
Prior to joining TransEnterix, Pope served as worldwide president of Cordis, and also held positions with Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX), the Research Triangle Park, N.C.-based company said.
“Being named one of Time Magazine’s 50 Most Influential People in Health Care for 2018 is a tremendous honor. It’s humbling to be recognized alongside other talented, boundary-pushing individuals across the spectrum of health care. This recognition reflects the efforts of our global team at TransEnterix who work every day to deliver innovative solutions that help surgeons achieve better outcomes for their patients,” CEO Pope said in a press release.
Earlier this month, TransEnterix said that it won 510(k) clearance from the FDA for a 3mm-diameter instrument set for its Senhance robot-assisted surgery device.